<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05009550</url>
  </required_header>
  <id_info>
    <org_study_id>2021/346</org_study_id>
    <nct_id>NCT05009550</nct_id>
  </id_info>
  <brief_title>ESP Block on Patient Outcomes in Patients With Liver Tumor Undergoing Radiofrequency Ablation</brief_title>
  <official_title>Effect of Erector Spina Plain (ESP) Block on Patient Outcomes in Patients With Liver Tumor Undergoing Radiofrequency Ablation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TC Erciyes University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TC Erciyes University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the ability of Erector spina Plane Block decrease postoperative pain and&#xD;
      analgesia requirements in patients undergoing percutaneous Radiofrequency ablation of&#xD;
      Hepatocellular Carcinomas.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Erector spina Plane Block is performed with guided ultrasound at T8 transverse process level&#xD;
      lead to adequate intraprocedural and postoperative analgesia, in percutaneous Radiofrequency&#xD;
      ablation of Hepatocellular Carcinomas.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 15, 2021</start_date>
  <completion_date type="Anticipated">September 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>single</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Numeric Pain Scale assesment</measure>
    <time_frame>24 hours after procedure</time_frame>
    <description>A research assistant, blinded to the group allocation, interviewed patients and collected data at 6 times intervals (0.,2.,4.,6.,12 and 24 hours) in the 24 hours postprocedure. Patients will be asked to rate their pain using Numeric Pain Scale, where 0=no pain and 10=worst pain possible.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Demographic data</measure>
    <time_frame>24 hours after procedure</time_frame>
    <description>Age, BMI, ASA, Duration of procedure are recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidences of adverse effects (like nausea and vomiting)</measure>
    <time_frame>24 hours after procedure</time_frame>
    <description>Incidences of adverse effects (like nausea and vomitting) during the 24 hours postprocedure perİod is recorded at 6 times intervals (0,2,4,6,12,24 hours)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Hepatic Carcinoma</condition>
  <arm_group>
    <arm_group_label>Erector spinae plane block group (ESP)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single-shot ultrasound guided ESP block is performed at the T8 vertebral level before the procedure to all patients in ESP block Group. Then standard sedation method is applied to all patients.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>This Group was received no intervention.Standard sedation method is applied to all patients.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Group ESP</intervention_name>
    <description>Single-shot ultrasound guided ESP block is performed at the T8 vertebral level before the procedure to all patients in ESP block Group</description>
    <arm_group_label>Erector spinae plane block group (ESP)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non-blocked Group</intervention_name>
    <description>This Group is received no intervention.Patients will be sedated as standard and radiofrequency procedure will be applied.</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ASA I-II patients&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  history of allergy to the study medication&#xD;
&#xD;
          -  refused to participate&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ozlem Oz Gergin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>TC Erciyes University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Özlem OZ Gergin, MD</last_name>
    <phone>09005332466396</phone>
    <email>oozgergin@erciyes.edu.tr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Özlem OZ Gergin, professor</last_name>
    <phone>09005332466396</phone>
    <email>oozgergin@erciyes.edu.tr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Özlem Öz Gergin</name>
      <address>
        <city>Kayseri</city>
        <zip>38090</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Özlem Öz Gergin, MD</last_name>
      <phone>09005332466396</phone>
      <email>oozgergin@erciyes.edu.tr</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <results_reference>
    <citation>Wells SA, Hinshaw JL, Lubner MG, Ziemlewicz TJ, Brace CL, Lee FT Jr. Liver Ablation: Best Practice. Radiol Clin North Am. 2015 Sep;53(5):933-71. doi: 10.1016/j.rcl.2015.05.012. Review.</citation>
    <PMID>26321447</PMID>
  </results_reference>
  <results_reference>
    <citation>Joung KW, Choi SS, Jang DM, Kong YG, Lee HM, Shim JH, Won HJ, Shin YM, Kim PN, Song MH. Comparative Effects of Dexmedetomidine and Propofol on US-Guided Radiofrequency Ablation of Hepatic Neoplasm Under Monitored Anesthesia Care: A Randomized Controlled Study. Medicine (Baltimore). 2015 Aug;94(32):e1349. doi: 10.1097/MD.0000000000001349.</citation>
    <PMID>26266387</PMID>
  </results_reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 16, 2021</study_first_submitted>
  <study_first_submitted_qc>August 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 17, 2021</study_first_posted>
  <last_update_submitted>August 16, 2021</last_update_submitted>
  <last_update_submitted_qc>August 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>TC Erciyes University</investigator_affiliation>
    <investigator_full_name>Özlem ÖZ GERGİN</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Erector spinae block</keyword>
  <keyword>Radiofrequency ablation</keyword>
  <keyword>Hepatocellular Carcinomas</keyword>
  <keyword>ultrasound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma, Hepatocellular</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>De- identified individual participant data for all primary and secondary outcome measures will be made available.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>Data will be available within 24 months of study completion</ipd_time_frame>
    <ipd_access_criteria>Data accept requests will be reviewed by an external independent Review Panel.Requesters will be required to sign a Data Access Agreement.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

